UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012-08, Vol.18 (4), p.534-543

2012

Volltextzugriff (PDF)

In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010–2011 season in Japan

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012-08, Vol.18 (4), p.529-533

2012

Volltextzugriff (PDF)

In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2018–19 season: Comparison with the 2010–11 to 2017–18 seasons

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020-08, Vol.26 (8), p.775-779

2020

Volltextzugriff (PDF)

Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate: A study of the 2017/18 and 2018/19 seasons and comparison with the 2011/12 to 2016/17 Japanese influenza seasons

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2022-07, Vol.28 (7), p.890-895

2022

Volltextzugriff (PDF)

Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts: a randomized double blind placebo controlled trial

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Vol.19 (4), p.740-749

2013

Volltextzugriff (PDF)

Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate; comparison of the 2011/12 to 2015/16 Japanese influenza seasons

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2017-09, Vol.23 (9), p.627-633

2017

Volltextzugriff (PDF)

In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012–2013 season

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015-01, Vol.21 (1), p.39-42

2015

Volltextzugriff (PDF)

In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2017–18 season: Comparison with the 2010–11 to 2016–17 seasons

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019-08, Vol.25 (8), p.649-652

2019

Volltextzugriff (PDF)

Clinical outcome of laninamivir octanoate hydrate for influenza in the 2013–2014 Japanese season

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015-11, Vol.21 (11), p.802-807

2015

Volltextzugriff (PDF)

Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate in the 2016/17 Japanese influenza season; comparison with the 2011/12 to 2015/16 seasons

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018-09, Vol.24 (9), p.718-724

2018

Volltextzugriff (PDF)

Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza

Clinical infectious diseases, 2016-08, Vol.63 (3), p.330-337

2016

Volltextzugriff (PDF)

In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011–2012 season in Japan

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014-02, Vol.20 (2), p.77-80

2014

Volltextzugriff (PDF)

A Comparison of the Effectiveness of Oseltamivir for the Treatment of Influenza A and Influenza B: A Japanese Multicenter Study of the 2003–2004 and 2004–2005 Influenza Seasons

Clinical infectious diseases, 2006-08, Vol.43 (4), p.439-444

2006

Volltextzugriff (PDF)

In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2016–17 season: Comparison with the 2010–11 to 2015–16 seasons

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018-09, Vol.24 (9), p.707-712

2018

Volltextzugriff (PDF)

Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate for influenza treatment; comparison among the four Japanese influenza seasons from 2011-2012 to 2014-2015

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016-09, Vol.22 (9), p.605-610

2016

Volltextzugriff (PDF)

Continued effectiveness of laninamivir octanate hydrate for influenza treatment in Japan: Comparison between the 2011–2012 and 2012–2013 influenza seasons

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014-12, Vol.20 (12), p.799-803

2014

Volltextzugriff (PDF)

The duration of fever and other symptoms after the initiation of laninamivir octanoate hydrate in the Japanese 2011–2012 influenza season

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014-02, Vol.20 (2), p.81-85

2014

Volltextzugriff (PDF)

Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance

International journal of antimicrobial agents, 2012-11, Vol.40 (5), p.381-388

2012

Volltextzugriff (PDF)

Short‐term interferon‐alfa therapy for acute hepatitis C: A randomized controlled trial

Hepatology (Baltimore, Md.), 2004-05, Vol.39 (5), p.1213-1219

2004

Volltextzugriff (PDF)

In vitro neuraminidase inhibitory concentration (IC50 ) of four neuraminidase inhibitors against clinical isolates of the influenza viruses circulating in the 2010-2011 to 2014-2015 Japanese influenza seasons

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2016-09, Vol.22 (9), p.599-604

2016

Volltextzugriff (PDF)

Clinical efficacy of long-acting neuraminidase inhibitor laninamivir octanoate hydrate in postmarketing surveillance

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Vol.19 (2), p.223-232

2013

Volltextzugriff (PDF)

Comparison of the Effectiveness of Zanamivir and Oseltamivir against Influenza A/H1N1, A/H3N2, and B

Clinical infectious diseases, 2009-04, Vol.48 (7), p.996-997

2009

Volltextzugriff (PDF)

CD27+ (memory) B cell decrease and apoptosis-resistant CD27− (naive) B cell increase in aged humans: implications for age-related peripheral B cell developmental disturbances

International immunology, 2005-04, Vol.17 (4), p.383-390

2005

Volltextzugriff (PDF)

Simple standing test predicts and water ingestion prevents vasovagal reaction in the high-risk blood donors

Transfusion (Philadelphia, Pa.), 2009-08, Vol.49 (8), p.1630-1636

2009

Volltextzugriff (PDF)

Factors Influencing the Effectiveness of Oseltamivir and Amantadine for the Treatment of Influenza: A Multicenter Study from Japan of the 2002—2003 Influenza Season

Clinical infectious diseases, 2005-05, Vol.40 (9), p.1309-1316

2005

Volltextzugriff (PDF)

1 – 25 von 368

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(238)
Mit Volltextzugriff
(228)

Publikationsform

Artikel
(368)

Sprache

Englisch
(310)
Japanisch
(97)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza

In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010–2011 season in Japan

In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2018–19 season: Comparison with the 2010–11 to 2017–18 seasons

Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate: A study of the 2017/18 and 2018/19 seasons and comparison with the 2011/12 to 2016/17 Japanese influenza seasons

Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts: a randomized double blind placebo controlled trial

Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate; comparison of the 2011/12 to 2015/16 Japanese influenza seasons

In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012–2013 season

In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2017–18 season: Comparison with the 2010–11 to 2016–17 seasons

Clinical outcome of laninamivir octanoate hydrate for influenza in the 2013–2014 Japanese season

Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate in the 2016/17 Japanese influenza season; comparison with the 2011/12 to 2015/16 seasons

Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza

In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011–2012 season in Japan

A Comparison of the Effectiveness of Oseltamivir for the Treatment of Influenza A and Influenza B: A Japanese Multicenter Study of the 2003–2004 and 2004–2005 Influenza Seasons

In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2016–17 season: Comparison with the 2010–11 to 2015–16 seasons

Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate for influenza treatment; comparison among the four Japanese influenza seasons from 2011-2012 to 2014-2015

Continued effectiveness of laninamivir octanate hydrate for influenza treatment in Japan: Comparison between the 2011–2012 and 2012–2013 influenza seasons

The duration of fever and other symptoms after the initiation of laninamivir octanoate hydrate in the Japanese 2011–2012 influenza season

Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance

Short‐term interferon‐alfa therapy for acute hepatitis C: A randomized controlled trial

In vitro neuraminidase inhibitory concentration (IC50 ) of four neuraminidase inhibitors against clinical isolates of the influenza viruses circulating in the 2010-2011 to 2014-2015 Japanese influenza seasons

Clinical efficacy of long-acting neuraminidase inhibitor laninamivir octanoate hydrate in postmarketing surveillance

Comparison of the Effectiveness of Zanamivir and Oseltamivir against Influenza A/H1N1, A/H3N2, and B

CD27+ (memory) B cell decrease and apoptosis-resistant CD27− (naive) B cell increase in aged humans: implications for age-related peripheral B cell developmental disturbances

Simple standing test predicts and water ingestion prevents vasovagal reaction in the high-risk blood donors

Factors Influencing the Effectiveness of Oseltamivir and Amantadine for the Treatment of Influenza: A Multicenter Study from Japan of the 2002—2003 Influenza Season

Suchergebnisse filtern